期刊文献+

142例糖尿病肾病临床分析 被引量:1

Clinical analysis of 142 cases of diabetic nephropathy
下载PDF
导出
摘要 目的:探讨糖尿病肾病(DN)的临床表现及危险因素。方法:收集我院2001年10月~2007年10月诊治的糖尿病患者398例,按1997年美国糖尿病协会(ADA)糖尿病诊断和分型标准确定研究对象DN 142例。利用回顾性研究方法分析DN的病例资料和临床规律;并根据是否伴发肾病将DN分为单纯糖尿病组和糖尿病肾病组,探讨DN的危险因素。结果:142例DN中,未按时服用降糖药46例,高蛋白饮食52例,肥胖78例,高血压51例和糖尿病史≥10年64例,两组间比较差异有统计学意义(P<0.05)。结论:未按时服用降糖药、高蛋白饮食、肥胖、高血压和糖尿病史≥10年是DN的危险因素。 Objective :To study the clinical manifestations and dangerous factors of diabetic nephropathy (DN).Methods:One hundred and forty-two patients with DN who were derived from three hundred and ninety-eight patients with diabetic menitus(DM) from October 2001 to October 2007 treated in our hospital according to the standard of diagnosis and typing in ADA, 1997 were regarded as object of study. It was to analyze the case information and clinical regularity with the way of retrospective research, and they were divided into simple DM and DN on the possibility of nephropathy to study the dangerous factors of DN.Results:Among them,forty-six cases didn't take medicine on time and fifty-two cases were in high protein diet, seventy-eight in fat,fifty-one in hypertension,sixty-four in DM medical history beyond ten years.Significant difference was observed between them (P〈0.05).Conclusion:Unregular administration, high protein diet,fat,hypertension,DM medical history beyond 10 years,and all that could be the dangerous factors of DN.
作者 王莉 聂俊华
出处 《现代医药卫生》 2008年第12期1764-1765,共2页 Journal of Modern Medicine & Health
关键词 糖尿病肾病 临床分析 Diabetic nephropathy Clinical analysis
  • 相关文献

参考文献6

二级参考文献28

  • 1胡俊斌,魏文宁,丁桂芝,袁莉,刘仲萍.糖尿病患者凝血与纤溶状态初探[J].中华内分泌代谢杂志,1996,12(2):118-119. 被引量:32
  • 2Bakris GL, Williams M, Dworkin L, et al. Preserving renal function in adults with hypertension and diabetes: a consensus approach[J] . Am J Kidney Dis, 2000, 36:646 - 661.
  • 3American Diabetes Association. Treatment of hypertension in adults with diabetes[ J ]. Diabetes Care, 2003, 26 : S80 -S82.
  • 4Ravid M, Brosh D, Levi Z, et al. Use of enalapril to attenuate decline in renal function in normotensive, normoalbuminurie patients with type 2 diabetes mellitus. A randomized, controlled trial[J]. Ann Intern Med, 1998, 128:982-988.
  • 5Melbourne Diabetic Nephropathy Study Group. Comparison between perindopril and nifedipine in hypertensive and normotensive diabetic patients with microalbuminuria[J]. BMJ, 1991,302:210 - 216.
  • 6Marre M, Chatellier G, LeBlanc Ⅱ, et al. Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria[J]. Br Med J , 1998, 297:1092 - 1095.
  • 7Heart Outcomes Prevention Evaluation Study Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitas: results of the HOPE study and MICRO-HOPE substudy[J]. Lancet, 2000, 355:253- 259.
  • 8Parring HH, Lehnert H, Brochner-Mortensen J, et al. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes[J]. N Engl J Med, 2001, 345:870 - 878.
  • 9Lewis E J, Hunsicker LG, Bain RP, et al. The effect of angiotesin-converting enzyme inhibition on diabetic nephropathy[J].N Engl J Med, 1993, 329:1456 - 1462.
  • 10Lewis EJ, Hunsicker LG, Clarke WR, et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes[J]. N Engl J Med,2001, 345:851 - 860.

共引文献103

同被引文献7

  • 1Kanwar YS, Wada J,Sun L,et al. Diabetic nephropathy :mechanisms of -nal disease progression[J]. Exp Biol Med (Maywood),2008,233 ( 1 ) :4-11.
  • 2Abdulahad WH, Stegeman CA, Kallenberg CG. Review article :The roleof CD4(+ ) T ceils in ANCA-associated systemic vasculitis[J]. Nephrology (Carlton) ,2009,14( 1 ) :26-32.
  • 3Koyama A, Yamagata K, Makino H,et al. A nationwide survey of rapidly progressive glomerulonephritis in Japan : etiology, prognosis and treatment diversitv[J]. Clin Exo Neohrol, 2009,13 (6) : 633-650.
  • 4Chen M ,Yu F,Zhang Y,et al. Antineutrophil cytoplasmic autoantibody- associated vaseulitis in older patients[J]. Medicine (Baltimore),2008,87 (4) :203-209.
  • 5Dharmapalaiah C,Watts RA. The role of biologics in treatment of ANCA- associated vasculitis[J]. Mod Rheumatol, 2012,22 (3) : 319-326.
  • 6彭朝荣,杨朝晖,黄毅.2型糖尿病肾病危险因素临床分析[J].现代医药卫生,2008,24(13):1915-1917. 被引量:4
  • 7施蓓莉,牟姗,王琴,张敏芳,曹励欧,方炜,倪兆慧.肾脏受累为主的抗中性粒细胞胞质抗体相关性血管炎患者的预后及其相关危险因素分析[J].中华风湿病学杂志,2011,15(11):754-758. 被引量:9

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部